274 related articles for article (PubMed ID: 22505317)
1. Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.
Studach LL; Menne S; Cairo S; Buendia MA; Hullinger RL; Lefrançois L; Merle P; Andrisani OM
Hepatology; 2012 Oct; 56(4):1240-51. PubMed ID: 22505317
[TBL] [Abstract][Full Text] [Related]
2. Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication.
Wang WH; Studach LL; Andrisani OM
Hepatology; 2011 Apr; 53(4):1137-47. PubMed ID: 21480320
[TBL] [Abstract][Full Text] [Related]
3. PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis.
Zhang H; Diab A; Fan H; Mani SK; Hullinger R; Merle P; Andrisani O
Cancer Res; 2015 Jun; 75(11):2363-74. PubMed ID: 25855382
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.
Fan H; Zhang H; Pascuzzi PE; Andrisani O
Oncogene; 2016 Feb; 35(6):715-26. PubMed ID: 25893293
[TBL] [Abstract][Full Text] [Related]
5. Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression.
Studach LL; Rakotomalala L; Wang WH; Hullinger RL; Cairo S; Buendia MA; Andrisani OM
Hepatology; 2009 Aug; 50(2):414-23. PubMed ID: 19472310
[TBL] [Abstract][Full Text] [Related]
6. EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes.
Mani SK; Zhang H; Diab A; Pascuzzi PE; Lefrançois L; Fares N; Bancel B; Merle P; Andrisani O
J Hepatol; 2016 Nov; 65(5):888-898. PubMed ID: 27238755
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.
Li TN; Wu YJ; Tsai HW; Sun CP; Wu YH; Wu HL; Pei YN; Lu KY; Yen TT; Chang CW; Chan HL; Tao MH; Liou JY; Chang MD; Su IJ; Wang LH
J Pathol; 2018 Aug; 245(4):502-513. PubMed ID: 29862509
[TBL] [Abstract][Full Text] [Related]
8. RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis.
Zhang H; Xing Z; Mani SK; Bancel B; Durantel D; Zoulim F; Tran EJ; Merle P; Andrisani O
Hepatology; 2016 Oct; 64(4):1033-48. PubMed ID: 27338022
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis.
Andrisani OM
Viruses; 2013 Mar; 5(3):858-72. PubMed ID: 23507839
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
11. Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy.
Studach L; Wang WH; Weber G; Tang J; Hullinger RL; Malbrue R; Liu X; Andrisani O
J Biol Chem; 2010 Sep; 285(39):30282-93. PubMed ID: 20624918
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation.
Ahodantin J; Bou-Nader M; Cordier C; Mégret J; Soussan P; Desdouets C; Kremsdorf D
Oncogene; 2019 Apr; 38(14):2645-2657. PubMed ID: 30538294
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis delta virus infects the cells of hepadnavirus-induced hepatocellular carcinoma in woodchucks.
Freitas N; Salisse J; Cunha C; Toshkov I; Menne S; Gudima SO
Hepatology; 2012 Jul; 56(1):76-85. PubMed ID: 22334419
[TBL] [Abstract][Full Text] [Related]
14. Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinoma.
Mani SKK; Yan B; Cui Z; Sun J; Utturkar S; Foca A; Fares N; Durantel D; Lanman N; Merle P; Kazemian M; Andrisani O
Theranostics; 2020; 10(24):10957-10972. PubMed ID: 33042264
[No Abstract] [Full Text] [Related]
15. HBV polymerase overexpression due to large core gene deletion enhances hepatoma cell growth by binding inhibition of microRNA-100.
Huang YH; Tseng YH; Lin WR; Hung G; Chen TC; Wang TH; Lee WC; Yeh CT
Oncotarget; 2016 Feb; 7(8):9448-61. PubMed ID: 26824500
[TBL] [Abstract][Full Text] [Related]
16. Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication.
Diab A; Foca A; Fusil F; Lahlali T; Jalaguier P; Amirache F; N'Guyen L; Isorce N; Cosset FL; Zoulim F; Andrisani O; Durantel D
Hepatology; 2017 Dec; 66(6):1750-1765. PubMed ID: 28445592
[TBL] [Abstract][Full Text] [Related]
17. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of β-catenin by hepatitis B virus X protein in HBV-infected human hepatocellular carcinomas.
Chen L; Hu L; Li L; Liu Y; Tu QQ; Chang YX; Yan HX; Wu MC; Wang HY
Front Med China; 2010 Dec; 4(4):399-411. PubMed ID: 21107751
[TBL] [Abstract][Full Text] [Related]
19. Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks.
Bruni R; Conti I; Villano U; Giuseppetti R; Palmieri G; Rapicetta M
Virology; 2006 Feb; 345(1):258-69. PubMed ID: 16271377
[TBL] [Abstract][Full Text] [Related]
20. Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1.
Takeuchi Y; Tsuge M; Tsushima K; Suehiro Y; Fujino H; Ono A; Yamauchi M; Makokha GN; Nakahara T; Murakami E; Abe-Chayama H; Kawaoka T; Miki D; Imamura M; Aikata H; Hayes CN; Tateno C; Chayama K
J Infect Dis; 2020 Nov; 222(12):2061-2070. PubMed ID: 32514521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
